Fresenius to sell €300 million in Fresenius Medical Care shares

Fresenius SE & Co. KGaA has agreed to sell approximately 7.8 million shares of Fresenius Medical Care to selected institutional investors. The transaction, valued at roughly €300 million, represents about 2.9 percent of the issued share capital of the dialysis provider.

Following the sale, Fresenius will retain a 25 percent stake in Fresenius Medical Care. The company intends to use the net proceeds to reduce group net debt and increase strategic flexibility to invest in its own growth platforms as part of its ‘#FutureFresenius’ transformation. Fresenius expects to report a book gain in the low to mid-double-digit millions of euros, which will be recorded as a special item in the third quarter.